儿童院前疼痛管理的有效性与安全性:一项系统评价
本系统评价检索2000年至2020年数据库,纳入8篇关于儿童院前疼痛管理的研究,评估镇痛药物有效性与安全性。纳入药物包括芬太尼(鼻内/静脉)、吗啡(静脉)、甲氧氟烷(吸入)和氯胺酮(静脉/肌内),所有药物均被评价为有效。芬太尼、甲氧氟烷和氯胺酮的不良事件均有报告,但均不被认为严重。作者认为鼻内芬太尼和吸入甲氧氟烷因给药方便、效果和安全性与其他镇痛药相似,似乎是儿童院前首选的药物,但纳入研究的证据等级仅为3或4级,需进一步研究。
要点
- 芬太尼、吗啡、甲氧氟烷及联合用药对儿童院前急性疼痛均被评价为有效。
- 芬太尼、甲氧氟烷和氯胺酮给药后均报告了不良事件,但无一被认为严重。
- 鼻内芬太尼和吸入甲氧氟烷因给药方便、效果与安全性与其他镇痛药相似,似乎是儿童院前首选药物。
- 纳入研究的证据等级仅为3或4级,作者认为需进一步研究。
适用人群与场景
- 儿童院前急性疼痛患者,不限病因。
研究设计与关键结果
- 系统评价纳入8篇文献,检索2000年至2020年PubMed、Medline、Embase、CINAHL、Epistemonikos和Cochrane library数据库。
- 纳入药物包括芬太尼(鼻内/静脉)、吗啡(静脉)、甲氧氟烷(吸入)和氯胺酮(静脉/肌内)。
- 芬太尼、吗啡和甲氧氟烷的效果均被评价为有效。
- 芬太尼、甲氧氟烷和氯胺酮的不良事件均有报告,但均不被认为严重。
- 由于结果异质性,采用文本叙述分析,并使用Joanna Briggs Institute(JBI)清单评估偏倚风险。
证据类型、等级与局限
- 证据类型:系统评价,方案注册号PROSPERO CRD42019126699。
- 纳入研究的证据等级(LOE)仅为3或4级。
- 局限:纳入研究的证据等级仅为3或4级,作者认为需进一步研究。
对床旁实践的改变
- 作者认为,鼻内芬太尼和吸入甲氧氟烷因给药方便、效果和安全性与其他镇痛药相似,似乎是儿童院前首选的药物。
- 作者指出,纳入研究的证据等级仅为3或4级,需进一步研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Clinically meaningful pain reduction with respect to severity and the adverse events of drugs used in prehospital pain management for children are areas that have not received sufficient attention. The present systematic review therefore aims to perform a comprehensive search of databases to examine the preferable drugs for prehospital pain relief in paediatric patients with acute pain, irrespective of aetiology.
METHODS: The systematic review includes studies from 2000 and up to 2020 that focus on children's prehospital pain management. The study protocol is registered in PROSPERO with registration no. CRD42019126699. Pharmacological pain management using any type of analgesic drug and in all routes of administration was included. The main outcomes were (1) measurable pain reduction (effectiveness) and (2) no occurrence of any serious adverse events. Searches were conducted in PubMed, Medline, Embase, CINAHL, Epistemonikos and Cochrane library. Finally, the risk of bias was assessed using the Joanna Briggs Institute (JBI) checklist and a textual narrative analysis was performed due to the heterogeneity of the results.
RESULTS: The present systematic review on the effectiveness and safety of analgesic drugs in prehospital pain relief in children identified a total of eight articles. Most of the articles reviewed identified analgesic drugs such as fentanyl (intranasal/IV), morphine (IV), methoxyflurane (inhalational) and ketamine (IV/IM). The effects of fentanyl, morphine and methoxyflurane were examined and all of the included analgesic drugs were evaluated as effective. Adverse events of fentanyl, methoxyflurane and ketamine were also reported, although none of these were considered serious.
CONCLUSION: The systematic review revealed that fentanyl, morphine, methoxyflurane and combination drugs are effective analgesic drugs for children in prehospital settings. No serious adverse events were reported following the administration of fentanyl, methoxyflurane and ketamine. Intranasal fentanyl and inhalational methoxyflurane seem to be the preferred drugs for children in pre-hospital settings due to their ease of administration, similar effect and safety profile when compared to other analgesic drugs. However, the level of evidence (LOE) in the included studies was only three or four, and further studies are therefore necessary.
参考来源
- Abebe Y, Hetmann F, Sumera K, et al. The effectiveness and safety of paediatric prehospital pain management: a systematic review. Scand J Trauma Resusc Emerg Med. 2021. PMID: 34895311. doi:10.1186/s13049-021-00974-3
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。